Effect of peripartum Clostridioides difficile infection on pregnancy and neonatal outcomes: an observational study
- PMID: 37124369
- PMCID: PMC10141253
- DOI: 10.1177/17562848231170479
Effect of peripartum Clostridioides difficile infection on pregnancy and neonatal outcomes: an observational study
Abstract
Background: The incidence of Clostridioides difficile infection (CDI) in peripartum women is rising, but limited data on its effect on maternal and neonatal outcomes are available.
Objective: To study the effect of peripartum CDI on pregnancy and neonatal outcomes.
Design: Retrospective cohort study.
Methods: Patients with peripartum CDI 12 weeks before pregnancy through 6 weeks postpartum (January 1996-February 2018) were matched with controls (peripartum women without CDI) 1:1 by age, year of delivery, and prior pregnancies. McNemar's test and conditional logistic regression were used to analyze the effect of CDI on pregnancy and neonatal outcomes (complications, mode of delivery). p < 0.05 was considered statistically significant.
Results: Overall, 101 cases and 100 controls (1997-2018) were included; median age 27 (range, 20-41) years. Timing of CDI was as follows: pre-pregnancy: 15.8% (n = 16), during pregnancy: 51.5% (n = 52), and postpartum: 32.7% (n = 33). The commonest risk factor was outpatient/emergency room visits. Pregnancy and neonatal outcomes were analyzed for 67 matched pairs with CDI before or during pregnancy. Cases had higher odds of cesarean delivery (p = 0.02) and lower odds of Group B Streptococcus (GBS) infection/colonization (p = 0.03). Odds of cesarean delivery remained high after controlling for labor arrest disorders [odds ratio (OR): 17.23 (95% confidence interval (CI), 2.19-543.19; p = 0.004)]; odds of GBS remained low after controlling for antibiotic use (OR: 0.25, 95% CI, 0.04-0.99; p = 0.049). Neonatal outcomes were similar in cases and controls. CDI treatment did not affect treatment-related or delivery outcomes.
Conclusion: Peripartum CDI was associated with higher odds of cesarean delivery and lower odds of GBS infections. Larger studies exploring the effect of CDI on pregnancy and neonatal outcomes are needed.
Keywords: FMT; antibiotic; children; diarrhea; infection; microbiome obstetric; microbiota transplant; pediatric.
© The Author(s), 2023.
Conflict of interest statement
The authors declare that there is no conflict of interest.
Similar articles
-
Incidence of Clostridioides difficile infection in peripartum women: a retrospective cohort study.Therap Adv Gastroenterol. 2020 Jul 27;13:1756284820942621. doi: 10.1177/1756284820942621. eCollection 2020. Therap Adv Gastroenterol. 2020. PMID: 32782480 Free PMC article.
-
Is Group B Streptococcus Colonization Associated with Maternal Peripartum Infection in an Era of Routine Prophylaxis?Am J Perinatol. 2021 Aug;38(S 01):e262-e268. doi: 10.1055/s-0040-1709666. Epub 2020 May 23. Am J Perinatol. 2021. PMID: 32446262
-
The emergence of Clostridium difficile infection among peripartum women: a case-control study of a C. difficile outbreak on an obstetrical service.Infect Dis Obstet Gynecol. 2011;2011:267249. doi: 10.1155/2011/267249. Epub 2011 Jul 24. Infect Dis Obstet Gynecol. 2011. PMID: 21811379 Free PMC article.
-
Variable spectrum of disease and risk factors of peripartum Clostridium difficile infection: report of 14 cases from French hospitals and literature review.Eur J Clin Microbiol Infect Dis. 2018 Dec;37(12):2293-2299. doi: 10.1007/s10096-018-3372-x. Epub 2018 Sep 3. Eur J Clin Microbiol Infect Dis. 2018. PMID: 30178230 Review.
-
Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.Dig Dis Sci. 2022 Mar;67(3):978-988. doi: 10.1007/s10620-021-06908-4. Epub 2021 Mar 22. Dig Dis Sci. 2022. PMID: 33748913
Cited by
-
Recognition, Diagnosis, and Treatment of Clostridioides difficile Enterocolitis Presenting Without Diarrhea: A Literature Review.Pathogens. 2025 Feb 12;14(2):181. doi: 10.3390/pathogens14020181. Pathogens. 2025. PMID: 40005556 Free PMC article. Review.
-
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options.Clin Microbiol Rev. 2024 Jun 13;37(2):e0013523. doi: 10.1128/cmr.00135-23. Epub 2024 Feb 29. Clin Microbiol Rev. 2024. PMID: 38421181 Free PMC article. Review.
References
-
- Ruiter-Ligeti J, Vincent S, Czuzoj-Shulman N, et al.. Risk factors, incidence, and morbidity associated with obstetric Clostridium difficile infection. Obstet Gynecol 2018; 1: 387–391. - PubMed
-
- Kuntz JL, Yang M, Cavanaugh J, et al.. Trends in Clostridium difficile infection among peripartum women. Infect Control Hosp Epidemiol 2010; 31: 532–534. - PubMed
-
- von Elm E, Altman DG, Egger M, et al.. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007; 147: 573–577. - PubMed
LinkOut - more resources
Full Text Sources